We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $82.3M
1-Year Est. Return 26.09%
This Fund
S&P 500
This Quarter Est. Return
+5.14%
1 Year Est. Return
+26.09%
3 Year Est. Return
+91.99%
5 Year Est. Return
10 Year Est. Return
AUM
$82.3M
AUM Growth
-$49.6M
Cap. Flow
-$48.5M
Cap. Flow %
-58.85%
Top 10 Hldgs %
68.24%
Holding
153
New
35
Increased
13
Reduced
6
Closed
95

Sector Composition

Rank Sector Weight
1 Financials 37.47%
2 Healthcare 21.59%
3 Technology 19.82%
4 Communication Services 5.03%
5 Industrials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
26
DELISTED
Calavo Growers
CVGW
$534K 0.65%
+20,700
New +$518K
ARM icon
27
Arm
ARM
$309B
$529K 0.64%
+3,500
New +$425K
RNA
28
Atrium Therapeutics
RNA
$201M
$481K 0.58%
+35,999
New +$506K
AAL icon
29
American Airlines Group
AAL
$10.1B
$430K 0.52%
+40,000
New +$530K
TERN
30
DELISTED
Terns Pharmaceuticals
TERN
$422K 0.51%
+8,000
New +$329K
IGV icon
31
iShares Expanded Tech-Software Sector ETF
IGV
$13.6B
$400K 0.49%
+5,000
New +$443K
SIMO icon
32
Silicon Motion
SIMO
$9.43B
$393K 0.48%
+3,500
New +$425K
SMH icon
33
VanEck Semiconductor ETF
SMH
$70.3B
$383K 0.47%
+1,000
New +$397K
PLTR icon
34
Palantir
PLTR
$318B
$366K 0.44%
2,500
CRWV
35
CoreWeave
CRWV
$43.4B
$349K 0.42%
4,500
-3,002
-40% -$261K
GLD icon
36
SPDR Gold Trust
GLD
$132B
$344K 0.42%
+800
New +$358K
ASTS icon
37
AST SpaceMobile
ASTS
$18.9B
$331K 0.4%
+4,000
New +$377K
INTC icon
38
Intel
INTC
$530B
$331K 0.4%
+7,500
New +$344K
SBNYP
39
DELISTED
Signature Bank Depositary shares, each representing a 1/40th ownership interest in a share of 5.000% Noncumulative Perpetual Series A Preferred Stock
SBNYP
$316K 0.38%
97,336
RLMD icon
40
Relmada Therapeutics
RLMD
$556M
$313K 0.38%
+45,000
New +$213K
APLS
41
DELISTED
Apellis Pharmaceuticals
APLS
$302K 0.37%
+7,500
New +$162K
PPLC
42
PPL Corp Corporate Units
PPLC
$298K 0.36%
+5,817
New +$296K
BE icon
43
Bloom Energy
BE
$64.4B
$271K 0.33%
2,000
-2,000
-50% -$294K
AVR
44
Anteris Technologies
AVR
$800M
$264K 0.32%
+47,500
New +$273K
CRNX icon
45
Crinetics Pharmaceuticals
CRNX
$8.88B
$260K 0.32%
+7,161
New +$320K
RKLB icon
46
Rocket Lab Corp
RKLB
$43.2B
$225K 0.27%
+3,500
New +$264K
SABS icon
47
SAB Biotherapeutics
SABS
$268M
$178K 0.22%
46,500
+31,500
+210% +$126K
RPID icon
48
Rapid Micro Biosystems
RPID
$103M
$161K 0.2%
71,000
+53,300
+301% +$195K
RKT icon
49
Rocket Companies
RKT
$38.6B
$143K 0.17%
+10,000
New +$182K
CNTB
50
Connect Biopharma Holdings
CNTB
$139M
$118K 0.14%
+45,000
New +$117K

Similar funds

Fifth Lane Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Fifth Lane Capital held 153 positions worth $82.3M, down 38% from $132M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Fifth Lane Capital withdrew a net $48.5M in Q1 2026, closing 95 positions and reducing 6 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Fifth Lane Capital opened a new position in Cantor Equity Partners V worth $7.65M.

  • Fifth Lane Capital's largest Q1 2026 buy was Cantor Equity Partners V: 753,500 shares worth $7.65M.
  • Fifth Lane Capital added most to Hologic in Q1 2026, an estimated $4.66M increase.
  • Fifth Lane Capital's biggest Q1 2026 reduction was Burford Capital, cutting an estimated $475K.
  • Fifth Lane Capital fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $18.8M.
  • Fifth Lane Capital's ten largest holdings make up 68% of its $82.3M portfolio in Q1 2026.
  • Fifth Lane Capital opened 35 new positions and closed 95 in Q1 2026.
  • Fifth Lane Capital's portfolio value fell 38% quarter-over-quarter to $82.3M.

Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.